Genetic enhancement of fracture repair

Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene

A. W A Baltzer, C. Lattermann, J. D. Whalen, P. Wooley, K. Weiss, M. Grimm, S. C. Ghivizzani, P. D. Robbins, Christopher H Evans

Research output: Contribution to journalArticle

Abstract

This study evaluated the ability of gene transfer to enhance bone healing. Segmental defects were created surgically in the femora of New Zealand white rabbits. First generation adenoviruses were used as vectors to introduce into the defects genes encoding either human bone morphogenetic protein-2 (BMP-2) or, as a negative control, firefly luciferase. Representative specimens were evaluated histologically after 8 weeks. Healing of the defects was monitored radiographically for 12 weeks, after which time the repair tissue was evaluated biomechanically. By radiological criteria, animals receiving the BMP-2 gene had healed their osseous lesions after 7 weeks, whereas those receiving the luciferase gene had not. Histologic examination of representative rabbits at 8 weeks confirmed ossification across the entire defect in response to the BMP-2 gene, whereas the control defect was predominantly fibrotic and sparsely ossified. At the end of the 12-week experiment, the control femora still showed no radiological signs of stable healing. The difference in radiologically defined healing between the experimental and control groups was statistically significant (P < 0.002). Biomechanical testing of the femora at 12 weeks demonstrated statistically significant increases in the mean bending strength (P < 0.005) and bending stiffness (P < 0.05) of the animals treated with the BMP-2 gene. Direct, local adenoviral delivery of an osteogenic gene thus led to the healing of an osseous lesion that otherwise would not do so. These promising data encourage the further development of genetic approaches to enhancing bone healing.

Original languageEnglish (US)
Pages (from-to)734-739
Number of pages6
JournalGene Therapy
Volume7
Issue number9
DOIs
StatePublished - May 2000
Externally publishedYes

Fingerprint

Genetic Enhancement
Bone Morphogenetic Protein 2
Fracture Healing
Genes
Femur
Rabbits
Firefly Luciferases
Bone and Bones
Luciferases
Adenoviridae
Osteogenesis
Control Groups

Keywords

  • Bone healing
  • Bone morphogenetic protein
  • Direct gene delivery

ASJC Scopus subject areas

  • Genetics

Cite this

Genetic enhancement of fracture repair : Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. / Baltzer, A. W A; Lattermann, C.; Whalen, J. D.; Wooley, P.; Weiss, K.; Grimm, M.; Ghivizzani, S. C.; Robbins, P. D.; Evans, Christopher H.

In: Gene Therapy, Vol. 7, No. 9, 05.2000, p. 734-739.

Research output: Contribution to journalArticle

Baltzer, AWA, Lattermann, C, Whalen, JD, Wooley, P, Weiss, K, Grimm, M, Ghivizzani, SC, Robbins, PD & Evans, CH 2000, 'Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene', Gene Therapy, vol. 7, no. 9, pp. 734-739. https://doi.org/10.1038/sj/gt/3301166
Baltzer, A. W A ; Lattermann, C. ; Whalen, J. D. ; Wooley, P. ; Weiss, K. ; Grimm, M. ; Ghivizzani, S. C. ; Robbins, P. D. ; Evans, Christopher H. / Genetic enhancement of fracture repair : Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. In: Gene Therapy. 2000 ; Vol. 7, No. 9. pp. 734-739.
@article{c07aa26d23844afa9bf3b8b4f75635e7,
title = "Genetic enhancement of fracture repair: Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene",
abstract = "This study evaluated the ability of gene transfer to enhance bone healing. Segmental defects were created surgically in the femora of New Zealand white rabbits. First generation adenoviruses were used as vectors to introduce into the defects genes encoding either human bone morphogenetic protein-2 (BMP-2) or, as a negative control, firefly luciferase. Representative specimens were evaluated histologically after 8 weeks. Healing of the defects was monitored radiographically for 12 weeks, after which time the repair tissue was evaluated biomechanically. By radiological criteria, animals receiving the BMP-2 gene had healed their osseous lesions after 7 weeks, whereas those receiving the luciferase gene had not. Histologic examination of representative rabbits at 8 weeks confirmed ossification across the entire defect in response to the BMP-2 gene, whereas the control defect was predominantly fibrotic and sparsely ossified. At the end of the 12-week experiment, the control femora still showed no radiological signs of stable healing. The difference in radiologically defined healing between the experimental and control groups was statistically significant (P < 0.002). Biomechanical testing of the femora at 12 weeks demonstrated statistically significant increases in the mean bending strength (P < 0.005) and bending stiffness (P < 0.05) of the animals treated with the BMP-2 gene. Direct, local adenoviral delivery of an osteogenic gene thus led to the healing of an osseous lesion that otherwise would not do so. These promising data encourage the further development of genetic approaches to enhancing bone healing.",
keywords = "Bone healing, Bone morphogenetic protein, Direct gene delivery",
author = "Baltzer, {A. W A} and C. Lattermann and Whalen, {J. D.} and P. Wooley and K. Weiss and M. Grimm and Ghivizzani, {S. C.} and Robbins, {P. D.} and Evans, {Christopher H}",
year = "2000",
month = "5",
doi = "10.1038/sj/gt/3301166",
language = "English (US)",
volume = "7",
pages = "734--739",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Genetic enhancement of fracture repair

T2 - Healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene

AU - Baltzer, A. W A

AU - Lattermann, C.

AU - Whalen, J. D.

AU - Wooley, P.

AU - Weiss, K.

AU - Grimm, M.

AU - Ghivizzani, S. C.

AU - Robbins, P. D.

AU - Evans, Christopher H

PY - 2000/5

Y1 - 2000/5

N2 - This study evaluated the ability of gene transfer to enhance bone healing. Segmental defects were created surgically in the femora of New Zealand white rabbits. First generation adenoviruses were used as vectors to introduce into the defects genes encoding either human bone morphogenetic protein-2 (BMP-2) or, as a negative control, firefly luciferase. Representative specimens were evaluated histologically after 8 weeks. Healing of the defects was monitored radiographically for 12 weeks, after which time the repair tissue was evaluated biomechanically. By radiological criteria, animals receiving the BMP-2 gene had healed their osseous lesions after 7 weeks, whereas those receiving the luciferase gene had not. Histologic examination of representative rabbits at 8 weeks confirmed ossification across the entire defect in response to the BMP-2 gene, whereas the control defect was predominantly fibrotic and sparsely ossified. At the end of the 12-week experiment, the control femora still showed no radiological signs of stable healing. The difference in radiologically defined healing between the experimental and control groups was statistically significant (P < 0.002). Biomechanical testing of the femora at 12 weeks demonstrated statistically significant increases in the mean bending strength (P < 0.005) and bending stiffness (P < 0.05) of the animals treated with the BMP-2 gene. Direct, local adenoviral delivery of an osteogenic gene thus led to the healing of an osseous lesion that otherwise would not do so. These promising data encourage the further development of genetic approaches to enhancing bone healing.

AB - This study evaluated the ability of gene transfer to enhance bone healing. Segmental defects were created surgically in the femora of New Zealand white rabbits. First generation adenoviruses were used as vectors to introduce into the defects genes encoding either human bone morphogenetic protein-2 (BMP-2) or, as a negative control, firefly luciferase. Representative specimens were evaluated histologically after 8 weeks. Healing of the defects was monitored radiographically for 12 weeks, after which time the repair tissue was evaluated biomechanically. By radiological criteria, animals receiving the BMP-2 gene had healed their osseous lesions after 7 weeks, whereas those receiving the luciferase gene had not. Histologic examination of representative rabbits at 8 weeks confirmed ossification across the entire defect in response to the BMP-2 gene, whereas the control defect was predominantly fibrotic and sparsely ossified. At the end of the 12-week experiment, the control femora still showed no radiological signs of stable healing. The difference in radiologically defined healing between the experimental and control groups was statistically significant (P < 0.002). Biomechanical testing of the femora at 12 weeks demonstrated statistically significant increases in the mean bending strength (P < 0.005) and bending stiffness (P < 0.05) of the animals treated with the BMP-2 gene. Direct, local adenoviral delivery of an osteogenic gene thus led to the healing of an osseous lesion that otherwise would not do so. These promising data encourage the further development of genetic approaches to enhancing bone healing.

KW - Bone healing

KW - Bone morphogenetic protein

KW - Direct gene delivery

UR - http://www.scopus.com/inward/record.url?scp=0034114692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034114692&partnerID=8YFLogxK

U2 - 10.1038/sj/gt/3301166

DO - 10.1038/sj/gt/3301166

M3 - Article

VL - 7

SP - 734

EP - 739

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 9

ER -